HER2 Support Group Forums - View Single Post - Machine learning reveals why cancer trials fall short in real-world patients

News · 01-10-2025, 06:25 AM

TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients and enhancing research accuracy.

More...

01-10-2025, 06:25 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,109	Machine learning reveals why cancer trials fall short in real-world patients TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients and enhancing research accuracy. More...